Trial Profile
ROLE OF ENDOTHELIAL INFLAMMATION IN DEMYELINATING DISEASES OF THE CENTRAL NERVOUS SYSTEM ROLE OF ENDOTHELIAL INFLAMMATION IN DEMYELINATING DISEASES OF THE CENTRAL NERVOUS SYSTEM
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Nov 2023
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Biomarker; Therapeutic Use
- Acronyms TREMEND
- 13 Oct 2023 Results analyzing the relationship between levels ofNFL and brain atrophy in DMF-treated patients with relapsingMS, presented at the 9th Triennial joint meeting of Americas Committee for Treatment and Research in Multiple Sclerosis and the European Committee for Treatment and Research in Multiple Sclerosis
- 15 Oct 2021 Results presented at the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
- 26 Oct 2018 New trial record